Digging deeper than genes to
advance treatments and discoveries
in precision-focused cancer medicine…
Proprietary systems biology- and Oncotecture™-driven
technologies for elucidating tumor checkpoints,
diagnostic biomarkers, and outcome-optimizing
drug combinations
DarwinHealth’s leadership team is supported by key collaborative partners and a scientific and medical advisory board of international experts …
Digging deeper than genes to
advance treatments and discoveries
in precision-focused cancer medicine…
Proprietary systems biology- and Oncotecture™-driven
technologies for elucidating tumor checkpoints,
diagnostic biomarkers, and outcome-optimizing
drug combinations
DarwinHealth™ is a precision-focused cancer medicine company that has developed, owns, and utilizes proprietary algorithms and methodologies to match virtually every individual cancer patient – at every stage of their disease – with those drugs and drug combinations that are optimally suited to produce successful treatment outcomes.
Conversely, these same methodologies can be used to prioritize drugs and drug combinations of unknown potential against the vast majority of human malignancies. As a result, they are invaluable for helping pharmaceutical companies optimize their developmental compound pipelines. In addition, they provide DarwinHealth™ with an edge drug discovery platform for prioritizing highly effective and yet under-valued compounds for its own acquisition, in-licensing, and/or clinical development. MORE>
(646) 661-5604
Lasker Biomedical Research Building | 3960 Broadway, Suite 540 | New York, NY 10032
All contents © 2017 DarwinHealth. All rights reserved. Privacy policy.